How is the Unity Biotechnology Inc today?

The Unity Biotechnology Inc today is trading in the down by -10.28% at 0.96.

How has Unity Biotechnology Inc performed historically?

The Unity Biotechnology Inc is currently trading down -10.28% on an intraday basis in the past week the index fell -2.04%. The index has been down -58.26% in the past quarter and fell -40.37% in the past year. You can view this in the overview section.

What is Unity Biotechnology Inc Annual Net Profit?

Unity Biotechnology Inc Annual Net Profit rose 34.8% in the last year to $25.99 M. Its sector's average net profit growth for the last fiscal year was -32.31%.

What is Unity Biotechnology Inc Price to Earning Ratio?

Unity Biotechnology Inc Price to Earning Ratio is -0.6, which is negative.

What is Unity Biotechnology Inc Stock Price?

Unity Biotechnology Inc Stock Price fell 40.37% and underperformed its sector by 47.16% in the past year.

What is Unity Biotechnology Inc Quarterly Net profit?

Unity Biotechnology Inc Quarterly Net profit fell 26.11% YoY to $7.3 M. Its sector's average net profit growth YoY for the quarter was -29.01%.

What is Unity Biotechnology Inc Debt to Equity Ratio?

Unity Biotechnology Inc Debt to Equity Ratio of 3.62 is higher than 1. This implies that company assets are financed through debt.

What is Unity Biotechnology Inc Return on Equity(ROE)?

Unity Biotechnology Inc Return on Equity(ROE) for the last financial year was -148.97%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Unity Biotechnology Inc Mutual Fund Holding?

Unity Biotechnology Inc Mutual Fund Holding increased by 0.59% in the last quarter to 9.81.

What is Unity Biotechnology Inc Promoter Share Holding?

Unity Biotechnology Inc Promoter Share Holding increased by 0.31% in the most recent quarter to 2.23%.

What is Unity Biotechnology Inc Institutional Holding?

Unity Biotechnology Inc Institutional Holding increased by 0.16% in the last quarter to 19.75.

Unity Biotechnology Inc XNAS: UBX

Unity Biotechnology Inc Live Share Price Today, Share Analysis and Chart

Name: Unity Biotechnology Inc: Is Infosys Ltd. worth buying?
Item: Unity Biotechnology Inc
Rating: 0.97025
Author: Trendlyne DVM scores

about

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clea...

0.96 -0.11 (-10.28%)

69.03% Fall from 52W High

136.0K XNAS Volume

XNAS 06 May, 2025 1:36 PM (EDT)

Board Meeting

The next board meeting for Unity Biotechnology Inc is on 14 May 2025 for the purpose of Unity Biotechnology Inc First Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

0.0 / 100

Technically Neutral

38.8 / 100

No estimates available

Unity Biotechnology Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Unity Biotechnology Inc Live Share Price Today, Share Analysis and Chart

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clea...

69.03% Fall from 52W High

SWOT Analysis

Unity Biotechnology Inc Live Price Chart

Unity Biotechnology Inc FAQ

How is Unity Biotechnology Inc today?

Unity Biotechnology Inc today is trading in the red, and is down by -10.28% at 0.96.

How has Unity Biotechnology Inc performed historically?

Unity Biotechnology Inc is currently trading down -10.28% on an intraday basis. In the past week the stock fell -2.04%. stock has been down -58.26% in the past quarter and fell -40.37% in the past year. You can view this in the overview section.